PRA

ProAssurance Corporation is a specialty insurer with expertise in medical professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.

Wall Street analysts forecast PRA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRA is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

ProAssurance Corp revenue for the last quarter amounts to 275.28M USD, decreased -1.12 % YoY.

ProAssurance Corp. EPS for the last quarter amounts to 0.03 USD, decreased -90.63 % YoY.

ProAssurance Corp (PRA) has 1036 emplpoyees as of January 10 2026.

Today PRA has the market capitalization of 1.24B USD.